4.7 Article

A Uniform Residual Tumor (R) Classification Integration of the R Classification and the Circumferential Margin Status

期刊

CANCER
卷 115, 期 15, 页码 3483-3488

出版社

WILEY
DOI: 10.1002/cncr.24320

关键词

circumferential resection margin; International Union Against Cancer; rectal carcinoma; residual tumor (R) classification

类别

资金

  1. Yorkshire Cancer Research Program Grant

向作者/读者索取更多资源

BACKGROUND: Since the introduction of the TNM residual tumor (R) classification, the involvement of resection margins has been defined either as a microscopic (RI) or a macroscopic (R2) demonstration of tumor directly at the resection margin (tumor transected). METHODS: The recognition of the importance of the circumferential resection margin (CRM) in patients with rectal cancer patients raises the need for an alternative definition of resection margin involvement, namely, the importance of delineating tumor with a minimal distance from the CRM of <= 1 mm (CRM-positive) from tumor directly at the resection margin. The different use of both definitions of resection margin involvement prevents valid comparisons between reports on treatment results. RESULTS: To avoid confusion by different definitions, the authors proposed including the minimal distance between tumor and resection margin into the current R classification. CONCLUSIONS: By using the proposed expanded classification, comparisons of new data with previous publications will be possible. Cancer 2009;115:3483-8. (C) 2009 American Cancer Society.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Deep learning identifies inflamed fat as a risk factor for lymph node metastasis in early colorectal cancer

Scarlet Brockmoeller, Amelie Echle, Narmin Ghaffari Laleh, Susanne Eiholm, Marie Louise Malmstrom, Tine Plato Kuhlmann, Katarina Levic, Heike Irmgard Grabsch, Nicholas P. West, Oliver Lester Saldanha, Katerina Kouvidi, Aurora Bono, Lara R. Heij, Titus J. Brinker, Ismayil Gogenur, Philip Quirke, Jakob Nikolas Kather

Summary: Using deep learning algorithm, this study accurately predicted lymph node metastasis in colorectal cancer patients, showing potential in discovering new biological mechanisms in cancer progression.

JOURNAL OF PATHOLOGY (2022)

Article Pathology

FOCUS4 biomarker laboratories: from the benefits to the practical and logistical issues faced during 6 years of centralised testing

Susan D. Richman, Gemma Hemmings, Helen Roberts, Niall Gallop, Rachel Dodds, Lyndsay Wilkinson, Jonathan Davis, Rhian White, Emma Yates, Bharat Jasani, Louise Brown, Tim S. Maughan, Rachel Butler, Philip Quirke, Richard Adams

Summary: FOCUS4 trial is a successful umbrella trial for patients with advanced colorectal cancer, using molecular profiling for biomarker analysis.

JOURNAL OF CLINICAL PATHOLOGY (2023)

Article Respiratory System

The risk of colorectal cancer in individuals with mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene: An English population-based study

Rebecca J. Birch, Daniel Peckham, Henry M. Wood, Philip Quirke, Rob Konstant-Hambling, Keith Brownlee, Rebecca Cosgriff, Nicholas Burr, Amy Downing

Summary: It has been found that individuals with Cystic Fibrosis (CF) have a higher risk of developing colorectal cancer (CRC), and carriers of cystic fibrosis transmembrane conductance regulator (CFTR) mutations may also face an increased risk. With the increasing life expectancy of CF patients, more individuals are at risk of developing CRC.

JOURNAL OF CYSTIC FIBROSIS (2023)

Article Oncology

Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial

Dion Morton, Matthew Seymour, Laura Magill, Kelly Handley, James Glasbey, Bengt Glimelius, Andy Palmer, Jenny Seligmann, Soren Laurberg, Keigo Murakami, Nick West, Philip Quirke, Richard Gray, FOxTROT Collaborative Grp

Summary: Neoadjuvant chemotherapy shows potential benefits for locally advanced colon cancer compared to postoperative chemotherapy. In this study, patients with radiologically staged T3-4, N0-2, M0 colon cancer were randomly assigned to receive 6 weeks of preoperative oxaliplatin-fluoropyrimidine chemotherapy followed by either 18 or 24 weeks postoperatively. Results indicate that neoadjuvant chemotherapy results in marked downstaging of tumors and lower rates of incomplete resections and disease recurrence within 2 years.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Oncology

Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline

Praveen Vikas, Hans Messersmith, Carolyn Compton, Lynette Sholl, Russell R. Broaddus, Anjee Davis, Maria Estevez-Diz, Rohan Garje, Panagiotis A. Konstantinopoulos, Aliza Leiser, Anne M. Mills, Barbara Norquist, Michael J. Overman, Davendra Sohal, Richard C. Turkington, Tyler Johnson

Summary: The College of American Pathologists (CAP) has developed a guideline on testing for mismatch repair (MMR) and microsatellite instability (MSI) for patients considered for immune checkpoint inhibitor therapy. ASCO has a policy and set of procedures for endorsing clinical practice guidelines that have been developed by other professional organizations. ASCO endorses the recommendations from the CAP guideline.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Oncology

Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients

Frederik J. Hansen, Paul David, Marina Akram, Samuel Knoedler, Anke Mittelstaedt, Susanne Merkel, Malgorzata J. Podolska, Izabela Swierzy, Lotta Rossdeutsch, Bettina Kloesch, Dina Kouhestani, Anna Anthuber, Alan Benard, Maximilian Brunner, Christian Krautz, Robert Gruetzmann, Georg F. Weber

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease associated with elevated levels of circulating monocytes, which are correlated with aggressive tumor growth and decreased survival. Monocytes may serve as a novel prognostic biomarker for PDAC and further research is needed to investigate their potential as therapeutic targets.

CANCERS (2023)

Article Oncology

Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer

Bernhard Mlecnik, Alessandro Lugli, Gabriela Bindea, Florence Marliot, Carlo Bifulco, Jiun-Kae Jack Lee, Inti Zlobec, Tilman T. Rau, Martin D. Berger, Iris D. Nagtegaal, Elisa Vink-Borger, Arndt Hartmann, Carol Geppert, Julie Kolwelter, Susanne Merkel, Robert Grutzmann, Marc Van den Eynde, Anne Jouret-Mourin, Alex Kartheuser, Daniel Leonard, Christophe Remue, Julia Wang, Prashant Bavi, Michael H. A. Roehrl, Pamela S. Ohashi, Linh T. Nguyen, SeongJun Han, Heather L. MacGregor, Sara Hafezi-Bakhtiari, Bradly G. Wouters, Giuseppe Masucci, Emilia K. Andersson, Eva Zavadova, Michal Vocka, Jan Spacek, Lubos Petruzelka, Bohuslav Konopasek, Pavel Dundr, Helena Skalova, Kristyna Nemejcova, Gerardo Botti, Fabiana Tatangelo, Paolo Delrio, Gennaro Ciliberto, Michele Maio, Luigi Laghi, Fabio Grizzi, Tessa Fredriksen, Benedicte Buttard, Lucie Lafontaine, Pauline Maby, Amine Majdi, Assia Hijazi, Carine El Sissy, Amos Kirilovsky, Anne Berger, Christine Lagorce, Christopher Paustian, Carmen Ballesteros-Merino, Jeroen Dijkstra, Carlijn van de Water, Shannon Van Lent-van Vliet, Nikki Knijn, Ana-Maria Musing, Dragos-Viorel Scripcariu, Boryana Popivanova, Mingli Xu, Tomonobu Fujita, Shoichi Hazama, Nobuaki Suzuki, Hiroaki Nagano, Kiyotaka Okuno, Toshihiko Torigoe, Noriyuki Sato, Tomohisa Furuhata, Ichiro Takemasa, Prabhu Patel, Hemangini H. Vora, Birva Shah, Jayendrakumar B. Patel, Kruti N. Rajvik, Shashank J. Pandya, Shilin N. Shukla, Yili Wang, Guanjun Zhang, Yutaka Kawakami, Francesco M. Marincola, Paolo A. Ascierto, Bernard A. Fox, Franck Pages, Jerome Galon

Summary: This study found that the immune system status is a better predictor of prognosis in early-stage colon cancer patients than tumor cell-related parameters. The consensus Immunoscore accurately identifies early-stage colon cancer patients with different clinical outcomes, regardless of treatment bias.

CANCERS (2023)

Article Medicine, General & Internal

NCR, an Inflammation and Nutrition Related Blood-Based Marker in Colon Cancer Patients: A New Promising Biomarker to Predict Outcome

Melanie Langheinrich, Alexander Reinhard Siebenhuener, Justus Baecker, Maximilian Miragall, Felix Wiesmueller, Vera Schellerer, Susanne Merkel, Maximilian Brunner, Christian Krautz, Klaus Weber, Robert Gruetzmann, Stephan Kersting

Summary: This study aimed to evaluate the value of different blood-based markers and assess the significance of a newly developed inflammatory-nutrition-related biomarker (NCR = BMI x albumin/CRP) in colon cancer patients. Lower preoperative NCR levels were associated with worse prognosis, tumor sidedness, undifferentiated histology, nodal involvement, and advanced UICC stage. The NCR proved to be a reliable indicator of poor prognosis for colon cancer patients and could be used for risk stratification and treatment selection.

DIAGNOSTICS (2023)

Review Gastroenterology & Hepatology

Tumor deposits in colorectal cancer: Refining their definition in the TNM system

Hideki Ueno, Iris D. Nagtegaal, Philip Quirke, Kenichi Sugihara, Yoichi Ajioka

Summary: Tumor deposits (TDs), discontinuous tumor spread, negatively impact survival in approximately 20% of colorectal cancer patients. Revisions on TD definition and categorization in the TNM system have been partially successful, but alternative staging methods, such as the counting method, have shown superior prognostic and diagnostic value. An international discussion on optimal TD treatment is needed to ensure patients receive the best possible adjuvant treatment.

ANNALS OF GASTROENTEROLOGICAL SURGERY (2023)

Article Microbiology

Analysis of an Indian colorectal cancer faecal microbiome collection demonstrates universal colorectal cancer-associated patterns, but closest correlation with other Indian cohorts

Mayilvahanan Bose, Henry Wood, Caroline Young, Philip Quirke, Ramakrishan Ayloor Seshadri

Summary: It has been found that changes in the gut microbiome can be either a cause or a correlation of colorectal cancer. Most of this research has been conducted in developed countries with high incidence of CRC, and it is unknown if lower incidence countries like India have similar microbial associations. This study collected and sequenced microbial samples from 46 Indian CRC patients and 43 healthy volunteers, demonstrating similarities to other Asian samples and a global CRC microbiome, but also highlighting regional variation and the importance of developing protocols and infrastructure for microbiome research in different countries.

BMC MICROBIOLOGY (2023)

Article Cell Biology

Generalizable biomarker prediction from cancer pathology slides with self-supervised deep learning: A retrospective multi-centric study

Jan Moritz Niehues, Philip Quirke, Nicholas P. West, Heike I. Grabsch, Marko van Treeck, Yoni Schirris, Gregory P. Veldhuizen, Gordon G. A. Hutchins, Susan D. Richman, Sebastian Foersch, Titus J. Brinker, Junya Fukuoka, Andrey Bychkov, Wataru Uegami, Daniel Truhn, Hermann Brenner, Alexander Brobeil, Michael Hoffmeister, Jakob Nikolas Kather

Summary: Deep learning can predict microsatellite instability (MSI) from routine histopathology slides of colorectal cancer (CRC). It is unclear whether DL can also predict other biomarkers with high performance and whether DL predictions generalize to external patient populations.

CELL REPORTS MEDICINE (2023)

Article Oncology

Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study

Sophia J. Wagner, Daniel Reisenbuechler, Nicholas P. West, Jan Moritz Niehues, Jiefu Zhu, Sebastian Foersch, Gregory Patrick Veldhuizen, Philip Quirke, Heike I. Grabsch, Piet A. van den Brandt, Gordon G. A. Hutchins, Susan D. Richman, Tanwei Yuan, Rupert Langer, Josien C. A. Jenniskens, Kelly Offermans, Wolfram Mueller, Richard Gray, Stephen B. Gruber, Joel K. Greenson, Gad Rennert, Joseph D. Bonner, Daniel Schmolze, Jitendra Jonnagaddala, Nicholas J. Hawkins, Robyn L. Ward, Dion Morton, Matthew Seymour, Laura Magill, Marta Nowak, Jennifer Hay, Viktor H. Koelzer, David N. Church, Christian Matek, Carol Geppert, Chaolong Peng, Cheng Zhi, Xiaoming Ouyang, Jacqueline A. James, Maurice B. Loughrey, Manuel Salto-Tellez, Hermann Brenner, Michael Hoffmeister, Daniel Truhn, Julia A. Schnabel, Melanie Boxberg, Tingying Peng, Jakob Nikolas Kather

Summary: This study develops a new transformer-based pipeline for predicting prognostic biomarkers from colorectal cancer pathology slides. The results show that this approach significantly improves performance, generalizability, data efficiency, and interpretability compared to current algorithms. The method also solves a longstanding diagnostic problem by achieving clinical-grade performance on endoscopic biopsy tissue.

CANCER CELL (2023)

Letter Oncology

Reply to S. Chakrabarti et al, R. Cohen et al, and DC Guven

Richard Gray, Matt Seymour, Laura Magill, Kelly Handley, Philip Quirke, Nick West, Dion Morton

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Surgery

Combined endoscopic and laparoscopic surgery (CELS) for early colon cancer in high-risk patients

Morten F. S. Hartwig, Mustafa Bulut, Jens Ravn-Eriksen, Lasse B. Hansen, Rasmus D. Bojesen, Mads Falk Klein, Henrik L. Jakobsen, Morten Rasmussen, Bo Rud, Jens-Ole Eriksen, Susanne Eiholm, Anne-Marie K. Fiehn, Phil Quirke, Ismail Gogenur

Summary: The study aimed to assess the feasibility of Combined Endoscopic and Laparoscopic Surgery (CELS) in high-risk patients with early colon cancer. The results showed that CELS resection was feasible in selected patients and could spare some patients from undergoing large bowel resection.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2023)

Letter Surgery

Comment on: Complete mesocolic excision for right colonic cancer: prospective multicentre study

Claus Anders Bertelsen, Paolo Pietro Bianchi, Roland Croner, Jakob Kleif, Klaus E. Matzel, Susanne Merkel, Danilo Miskovic, Marcos Gomez Ruiz, Adam T. Stearns, Kristian Eeg Storli

BRITISH JOURNAL OF SURGERY (2023)

暂无数据